National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

  title={National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants},
  author={Goodarz Danaei and Mariel McKenzie Finucane and Yuan Lu and Gitanjali M Singh and Melanie J. Cowan and Christopher J. Paciorek and John Kent Lin and Farshad Farzadfar and Young Ho Khang and Gretchen A. Stevens and Mayuree Rao and Mohammed K. Ali and Leanne Margaret Riley and Carolyn Robinson and Majid Ezzati},
  journal={The Lancet},

Figures from this paper

Trends in obesity and diabetes across regions in Africa from 1980 to 2014: an analysis of pooled population-based studies

African countries’ efforts to prevent and control diabetes and obesity should integrate the setting up of reliable monitoring systems, consistent with the WHO’s Global Monitoring System Framework.

Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys

Health system performance for management of diabetes showed large losses to care at the stage of being tested, and low rates of diabetes control along the care cascade, indicating large unmet need for diabetes care across 28 LMICs.

Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012.

The recent prevalence and update US trends in total diabetes, diagnosed diabetes, and undiagnosed diabetes using National Health and Nutrition Examination Survey (NHANES) data was estimated using cross-sectional surveys conducted between 1988-1994 and 1999-2012.

Prevalence of Prediabetes Based on Fasting Plasma Glucose and Glycosylated Hemoglobin in an At-Risk Mexican Population.

The prevalence ofprediabetes in a Mexican population at risk for cardiovascular disease and/or T2DM was high and future studies are needed to examine the effectiveness and efficiency of pragmatic strategies to reverse the status of prediabetes and, therefore, reduce the incidence of T2 DM.



Global estimates of the prevalence of diabetes for 2010 and 2030.

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.

Australia has a rapidly rising prevalence of diabetes and other categories of abnormal glucose tolerance, one of the highest yet reported from a developed nation with a predominantly Europid background.

Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited

It is found that the current fasting diagnostic criterion favors specificity and the current 2-h criterion favors sensitivity and these results should prove valuable for defining the optimal tests and cutpoint values for diagnosing diabetes.

Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006

Over 40% of people aged ≥20 years have hyperglycemic conditions, and prevalence is higher in minorities, particularly in non-Hispanic blacks.

Blood glucose and risk of cardiovascular disease in the Asia Pacific region.

Fasting blood glucose is an important determinant of CVD burden, with considerable potential benefit of usual blood glucose lowering down to levels of at least 4.9 mmol/l, and adjusting for potential confounders or removing those with diabetes as baseline did not substantially affect the associations.

Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

This report supports earlier predictions of the epidemic nature of diabetes in the world during the first quarter of the 21st century and provides a provisional picture of the characteristics of the diabetes epidemic.

The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

The global prevalence of NIDDM was estimated using published incidence rates and population figures, incorporating the likely survival time from development of IDDM, and is likely to increase as more people survive for longer after diagnosis.

Diabetes prevalence and diagnosis in US states: analysis of health surveys

Diabetes prevalence is highest in the Southern and Appalachian states and lowest in the Midwest and the Northeast, and better diabetes diagnosis is needed in a number of states.